WATERLINE: Water Load Test Value for Hyponatremia

Sponsor
European Georges Pompidou Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04256499
Collaborator
(none)
150
1
227.9
0.7

Study Details

Study Description

Brief Summary

Acute water load test has been using to diagnose renal ability to excrete water for decades. Latest recommendations for the diagnosis of hyponatremia do not recommend performing such a test. The investigators aim at, retrospectively, study the value of acute water load test in patients suffering from a syndrome of inappropriate antidiuresis.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Acute water load test

Study Design

Study Type:
Observational
Actual Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Water Load Test Value for Hyponatremia Due to a Syndrome of Inappropriate Antidiuresis (SIAD)
Actual Study Start Date :
Jan 1, 2001
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Water load test

Patients experiencing a syndrome of inappropriate antidiuresis who had an acute water load test

Procedure: Acute water load test
The acute water load test consists in administering orally 20 mL/kg (of body weight) of water (ingested in less than 30 min) and then follow (during 4 to 6 hours) blood and urine parameters.

Control group

Patients who had an acute water load test and who did not experience any water homeostasis anomalies

Procedure: Acute water load test
The acute water load test consists in administering orally 20 mL/kg (of body weight) of water (ingested in less than 30 min) and then follow (during 4 to 6 hours) blood and urine parameters.

Outcome Measures

Primary Outcome Measures

  1. Natremia [any time after water load test from hour 2 to hour 6]

    Plasma sodium concentration (abnormal if <135mM)

Secondary Outcome Measures

  1. Plasma osmolality [any time after water load test from hour 2 to hour 6]

    Plasma osmolality (abnormal if <280mOsm/kgH2O)

  2. Excretion of water load [after water load test from hour 0 to hour 6]

    Ratio between the excreted water (in urine) volume and the ingested one

  3. Urine osmolality [any time after water load test from hour 2 to hour 6]

    Minimum urine osmolality reached

Other Outcome Measures

  1. Body weight [Value at hour 6 versus initial value (hour 0)]

    Variation of body weight during the test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ≥ 18 years old at the time of the test

  • affiliated to a social insurance system

  • water load test performed at the Renal and Metabolic Diseases Unit of the European George Pompidou Hospital, AP-HP, Paris, France

  • between 01/01/2001 and 12/31/2019

Exclusion Criteria:
  • hypernatremia and/or polyuria-polydipsia (diabetes insipidus)

  • hyponatremia due to a tea and toast syndrome and/or a beer potomania

  • hyponatremia due to a high (or normal) osmolality related to diabetes mellitus, hyperproteinemia and/or intoxication

  • chronic kidney disease with an estimated glomerular filtration rate (eGFR) by the MDRD formula <60 mL/min/1.73m2

  • hyponatremia related to thiazides

  • hyponatremia related to an hypovolemic status

  • syndrome of inappropriate antidiuresis related to an endocrine disorder (such as hypothyroidism or adrenal insufficiency)

Contacts and Locations

Locations

Site City State Country Postal Code
1 European Georges Pompidou Hospital, APHP Paris France 75908

Sponsors and Collaborators

  • European Georges Pompidou Hospital

Investigators

  • Principal Investigator: Jean-Philippe Bertocchio, MD, PhD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jean-philippe Bertocchio, MD, PhD, Principal Investigator, European Georges Pompidou Hospital
ClinicalTrials.gov Identifier:
NCT04256499
Other Study ID Numbers:
  • WATERLINE
First Posted:
Feb 5, 2020
Last Update Posted:
Feb 5, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jean-philippe Bertocchio, MD, PhD, Principal Investigator, European Georges Pompidou Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 5, 2020